News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,761 Results
Type
Article (26327)
Company Profile (60)
Press Release (367372)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104374)
Career Advice (455)
Deals (16888)
Drug Delivery (53)
Drug Development (47725)
Employer Resources (47)
FDA (12346)
Job Trends (8482)
News (186328)
Policy (19522)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1757)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26824)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12679)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3059)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42927)
Collaboration (849)
Compensation (271)
Complete response letters (16)
COVID-19 (1553)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4220)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3712)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38612)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54181)
Executive appointments (584)
FDA (14619)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (750)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (541)
Government (3142)
Grass and pollen (4)
Guidances (229)
Healthcare (12211)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1684)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7071)
IRA (23)
Job creations (1845)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3646)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13296)
Medtech (13341)
Mergers & acquisitions (10328)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1687)
NextGen: Class of 2026 (3935)
Non-profit (2835)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (349)
Peanut (42)
People (35636)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12335)
Phase 2 (18564)
Phase 3 (15261)
Pipeline (3023)
Policy (125)
Postmarket research (1668)
Preclinical (3797)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2869)
Recruiting (18)
Regulatory (15680)
Reports (18)
Research institute (1652)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2133)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (502)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Last 7 days (303)
Last 30 days (1100)
Last 365 days (16141)
2026 (1471)
2025 (16468)
2024 (19846)
2023 (22735)
2022 (30680)
2021 (32986)
2020 (32190)
2019 (28415)
2018 (21811)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16024)
2013 (13242)
2012 (14350)
2011 (14623)
2010 (13181)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25486)
Australia (4031)
California (5566)
Canada (1903)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49870)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (20)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3734)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1922)
New Mexico (10)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2643)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (523)
South Carolina (59)
Southern California (2234)
Tennessee (124)
Texas (1017)
United States (21593)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
393,761 Results for "confluent medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Confluent Medical Debuts Filmcast Select™ to Enable Tailored Performance in PTFE and Polyimide Tubing
January 29, 2026
·
2 min read
Press Releases
Confluent Medical Technologies Announces Ultra Polyimide
April 8, 2025
·
2 min read
Confluent Announces Significant Investment in ATI Nitinol Melt ExpansionConfluent Becomes ATI’s Fulfillment Partner for Medical Nitinol
Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to invest more than $50 million over the next several years in ATI’s Nitinol melt and materials conversion infrastructure.
January 25, 2024
·
3 min read
Business
Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency
Confluent Medical has experienced significant improvements to its end-to-end supply chain with Kinaxis.
November 8, 2023
·
4 min read
Press Releases
IncreMedical Therapy Solutions Rebrands as Confluent Health System Solutions to Advance Musculoskeletal Rehabilitation Services Nationwide
February 6, 2025
·
3 min read
Deals
Medical Manufacturing Technologies (MMT) Acquires Confluent Medical Equipment Line
Medical Manufacturing Technologies (MMT) announced the purchase of Confluent Medical Technologies’ equipment manufacturing group, which includes their balloon forming equipment manufacturing as well as their testing and catheter manufacturing equipment capabilities.
November 2, 2022
·
2 min read
Business
Confluent Medical Technologies Names Matthew K. Eckl as Chief Financial Officer
Confluent Medical Technologies, Inc. (“Confluent”) today announced that Matthew K. Eckl has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022.
October 17, 2022
·
2 min read
Press Releases
66 Confluent Health Physical and Occupational Therapists Receive Board-Certified Clinical Specialist Credential
July 30, 2024
·
5 min read
Biotech Bay
Confluent Medical Announces Closing of Majority Investment From TPG
Confluent Medical Technologies (“Confluent”), a leading materials science, development, and manufacturing partner to medical device manufacturers, today announced the closing of a majority investment from TPG Capital, the private equity platform of alternative asset management firm TPG.
February 17, 2022
·
4 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
1 of 39,377
Next
